Table 1.

Study population (safety analysis set).

Characteristic	n (%)
Sex
Male	9 (12.0)
Female	66 (88.0)
Race
White	59 (78.7)
Black	10 (13.3)
American Indian or Alaska Native	1 (1.3)
Not reported	5 (6.7)
	Mean (SD)
Age (years)	61.7 (11.4)
Baseline body mass index (kg/m2)	32.08 (7.19)
Select concomitant medications (n (%))
Antithrombotics	48 (64.0)
Calcium channel blocker	22 (29.3)
Diuretics	50 (66.7)
Primary diagnosis at baseline (n (%))
Idiopathic PAH (IPAH)	49 (65.3)
Familial PAH (FPAH)	1 (1.3)
Drug- and toxin-induced PAH	1 (1.3)
Associated PAH (APAH) conditions	1 (1.3)
Connective tissue disease	21 (28.0)
Portal hypertension	2 (2.7)
WHO FC at baseline (n (%))
I	7 (9.3)
II	23 (30.7)
III	44 (58.7)
IV	1 (1.3)
LPH score at baseline (mean (SD))
Total score	46.03 (24.57)
Physical dimension score	22.83 (10.70)
Emotional dimension score	10.2 (7.8)
WLQ-8 score at baseline (mean (SD))
Time Management Score	36.42 (30.82)
Mental Interpersonal Demands Score	28.66 (25.22)
Output Demands Score	36.52 (31.51)
Physical Demands Score	33.47 (28.25)